Respiratory

An analysis found nirsevimab was associated with substantial reductions in RSV-related hospitalizations among preterm infants and those with congenital heart disease.

New consensus recommendations outline diagnostic strategies and management considerations for recurrent wheezing in children younger than 3 years.

A trial found that high-frequency oscillatory ventilation is a promising first-line therapy that significantly lowers the risk of bronchopulmonary dysplasia.

A study found that a nirsevimab immunization program reduced RSV-related hospitalizations by 85.9% in the first season and 55.3% in the second.

Part 4 highlights how expanding epinephrine delivery options can reduce barriers, support earlier administration, and improve real-world anaphylaxis outcomes.

In this segment, experts emphasize the importance of giving an infant experiencing anaphylaxis epinephrine at whatever dose may be available rather than delaying treatment.

In the second part of the special report, panelists delink epinephrine use from mandatory emergency department visits.

In the opening segment of this special report, panelists discuss updated anaphylaxis guidelines and early management priorities.

A study shows how COVID-19 reshaped the circulation, seasonality, and coinfection patterns of respiratory viruses in children.

More than half of infants with myelomeningocele experience sleep-disordered breathing before hospital discharge, with prematurity driving risk.

The AAP released its 2026 childhood immunization schedule, maintaining evidence-based vaccine recommendations and expanding guidance across routine, catch-up, and risk-based care.

FDA-cleared Flowflex Plus 4-in-1 home test detects RSV, influenza A/B, and COVID-19 in adults and children as young as 6 months.

Influenza antiviral use among hospitalized US children declined during the late COVID-19 pandemic despite guideline recommendations.

Pertussis often presents as a prolonged cold, especially in infants. Early recognition, treatment, and vaccination are key to reducing severe disease and spread.

Children hospitalized for bronchiolitis who received high-flow nasal cannula therapy were more likely to be diagnosed with asthma in early childhood.

Experts say recent CDC vaccine schedule changes may complicate clinician–family communication without altering the underlying evidence supporting pediatric vaccination.

Shilpa Patel, MD, MPH, says pediatricians can effectively lead asthma care by emphasizing education, trust, and frequent reassessment.

Check out the top 5 nutrition articles of 2025.

Climate lag time poses urgent health risks for children, necessitating proactive pediatric care and policy changes to address future climate-related challenges.

The SWIFT-1 and -2 phase 3 trials demonstrated "significantly" lower rate of annualized asthma exacerbations in patients receiving twice-yearly depemokimab vs placebo.

According to multiple reports, the FDA is investigating the safety of a pair of already-approved protective treatments for respiratory syncytial virus.

Updated 2025 CPR guidelines from the AAP and AHA include revisions to pediatric and neonatal resuscitation, reflecting new evidence and a unified chain of survival.

Combined or individual use of maternal RSVpreF and infant nirsevimab achieved high antibody levels without safety concerns, supporting current RSV prevention strategies.

A recently immigrated mother from India presents in preterm labor at 32 6/7 weeks and delivers a vigorous baby whose initial blood culture is positive at 18 hours of life with gram-negative rods.